Upcoming Conferences in the Life Sciences Industry

BioTechX USA is the leading digital transformation event for precision medicine on the East Coast covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare.

In 2024, our 2-day event will host 1500 leaders in the field, 100 sponsors, 100 start-ups and 300 speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems and academic groups, creating endless networking opportunities.

For 50% off delegate tickets, use code BTG50

Free VIP guest link for Biotechgate members that fall into the buy side part of the conference

Join us for the 7th Annual BioHealth Capital Region Investment Conference, taking place on September 19th, 2024, at the US Pharmacopeia. This esteemed in-person event unites ambitious entrepreneurs and BioHealth companies with a wide array of influential investors, offering funding opportunities from pre-seed to Series A stages.

Located in the vibrant BioHealth Capital Region, this conference is renowned for its role in fostering successful ventures, leading to initial and follow-on financings, IPOs, and M&A activities. The conference upholds high standards through a detailed three-step selection process. Initially, companies submit comprehensive applications detailing their operations and financing needs. Those selected then create detailed online profiles for investor review. Finally, during the conference, investors schedule exclusive meetings with the companies that pique their interest.

This event is an extraordinary opportunity for companies seeking investment to connect with key investors who are actively searching for promising ventures. If you are an entrepreneur or a BioHealth company aiming to elevate your business, register now to secure your place and unlock the potential for transformative funding.

Investors, if you’re looking to fund cutting-edge BioHealth ventures and discover the next breakthrough innovation, you won’t want to miss this exclusive gathering of visionary entrepreneurs.

The main programme for the 11th Annual HTIF will feature more than 7 hours of high-level speeches and panel discussions. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presenting tracks, alongside virtual company showcases, which will be available on-demand during the virtual week.

Back for its 24th Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2024 as well as partnering and alliance management and prospects for 2025. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives.

During Biotech Week Boston 2024, RESI Boston will be held at the Westin Copley Place on September 25 follow by 2-day virtual partnering on September 26-27. The RESI venue is conveniently located just a 10-minute walk from the main Biotech Week Boston venue which is the Hynes Convention and Exhibition Center.

An Introductory Course:
Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region.

It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation since 2018.

The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

We are delighted to be hosting the 7th LSX Nordic Congress in Copenhagen, Denmark once again! As the hub of Medicon Valley, the crucible of Scandinavian life sciences, we can’t wait to welcome you all to Copenhagen in October!

BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. With 16 tracks of high-level content and a poster presentation session, the event covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data.

In 2024 BioTechX will return to Basel, the pharma hub of Europe, this time with 3500 global executives, 400 speakers and 50 start-ups all under one roof, bridging the gap between pharma, academia and clinicians. Don't miss Europe's largest biotechnology congress for pharma, healthcare and partners.
For 50% off delegate tickets, use code BTG50

Free VIP guest link for Biotechgate members that fall into the buy side part of the conference

The World Drug Safety Congress Europe will bring together 1500+ key leaders to bridge the gap between international regulatory bodies, industry professionals and patient representatives. From exploring the use of big data and AI in pharmacovigilance, examining benefit-risk management strategies and patient-centric approaches, the World Drug Safety Congress Europe explores the key challenges in pharmacovigilance and drug safety.

For 50% off delegate tickets, use code BTG50

Complimentary guest link for Government, NGOs, Patient Groups & Academics

The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market.

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. This one event will provide you with a one stop progressive scientific and strategic solution to the orphan drugs industry. Now recognized as the largest and most established multi-stakeholder rare disease meeting, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape.

From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.

Connecting innovators with investors, the 18th annual AusBioInvest conference will be held on Tuesday 29 October in Melbourne, Australia.

AusBioInvest, Australia’s premier life science investment conference, is dedicated to building meaningful connection between investors and private and publicly-listed biotech companies actively seeking investors or partners to support their funding and co-development.

The full-day programme will feature keynotes and panel sessions with leading investors and business leaders on the trends, themes, and market conditions shaping life science investing, in addition to up to 25 presentations from early to late-stage biotechnology companies seeking investment and strategic partners.

Investors also receive access to an exclusive networking lounge and AusPartnering, AusBiotech’s 1:1 business matching programme. Qualified investors are invited to register for a complimentary pass here »

Step into the future of biotechnology at AusBiotech 2024, Australia’s largest life science conference, held in Melbourne from 30 October – 1 November.

AusBiotech 2024 features an industry-led programme with more than 170 speakers across over 60 sessions developed to inform, educate, celebrate, and inspire the life science community. AusBiotech 2024 is created by industry, for industry. This year's programme features a one-day AgriBiotech Summit, the Early-Stage Innovation Forum rapid-fire pitch competition, conference gala dinner, and plenty of formal and informal networking opportunities.

For over 38 years, the AusBiotech conference has been the premier international meeting place for the Australian life science community, attracting delegates from over 20 countries. Learn from international and local thought leaders as they discuss the latest research, technologies, challenges, opportunities, and market access strategies.

Engage in in-person networking, cutting-edge programming, and be part of advancing the life sciences industry during the flagship event of ‘Australia’s biggest week in biotech’.

Register here »

The 30th annual BIO-Europe will take place November 4-6, 2024 in Stockholm, Sweden, and it will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event.

Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.

BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programmes, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.

The Advanced Therapies Congress focuses on tackling challenges at each stage of development to accelerate development of next generation therapies to benefit patients. We bring together decision makers from key biotech and pharma companies so there is a good ratio of buyers and sellers in our audience.

Inv€$tival Showcase is your Ultimate Biotech, Healthtech and Medtech Networking & Pitching Event in London.

With 7 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.

The LSX Investival Showcase continues its exclusive partnership with global investment bank Jefferies, serving as the kick off to Jefferies week, leading into the Jefferies London Healthcare Conference.

We are pleased to announce that the 8th Annual Neuroscience Innovation Forum (#Sachs_NIF) will take place once again at the Marines’ Memorial Club, San Francisco on the 12th of January 2025, a day before the JP Morgan meeting and the Virtual Week will take place the week after, from the 21st - 23rd of January.

Positioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. The main programme for the 8th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech, and diagnostics fields.

The 43rd JPM Healthcare Conference 2025 will be held at the Westin St. Francis in San Francisco from January 13-16, 2025. As the industry’s largest and most comprehensive healthcare investment symposium, it will attract tens of thousands of life science professionals from around the world. Concurrently, the 50th RESI Conference will be held on January 14 with in-person conference, followed by two days of online partnership events. Previous RESI JPM conferences have attracted over a thousand attendees, including more than 500 early-stage life science investors and licensing partners, an equal number of life science innovators, and many industry experts.